STOCK TITAN

/C O R R E C T I O N -- BDMD/

Rhea-AI Impact
(No impact)
Rhea-AI Sentiment
(Neutral)
Tags

Baird Medical (NASDAQ: BDMD) participated in an International Thyroid Microwave Ablation Workshop at Hospital Canselor Tuanku Muhriz (HCTM), National University of Malaysia on October 1–2, 2025.

Led by Proctor Dr. Shuhang Xu, endocrinologist at Jiangsu Provincial Hospital, with HCTM surgeons Dr. Adi Syazni and Prof. Shahrun Niza, the two-day program combined theoretical lectures, complex case discussions, and hands-on training with mannequins and live patients to advance physician MWA skills and support global adoption of minimally invasive therapy.

Baird Medical (NASDAQ: BDMD) ha partecipato a un Workshop Internazionale di Ablazione a Microonde della Tiroide presso l'Hospital Canselor Tuanku Muhriz (HCTM), National University of Malaysia, il 1–2 ottobre 2025.

Guidato dal Prof. Dr. Shuhang Xu, endocrinologo dell'Ospedale Provinciale di Jiangsu, insieme ai chirurghi dell'HCTM Dr. Adi Syazni e Prof. Shahrun Niza, il programma di due giorni ha combinato lezioni teoriche, discussioni di casi complessi e addestramento pratico con manichini e pazienti reali per migliorare le competenze MWA dei medici e sostenere l'adozione globale della terapia minimamente invasiva.

Baird Medical (NASDAQ: BDMD) participó en un Taller Internacional de Ablación por Microondas de Tiroides en el Hospital Canselor Tuanku Muhriz (HCTM), Universitas Nacional de Malasia, los días 1 y 2 de octubre de 2025.

Dirigido por el endocrinólogo Dr. Shuhang Xu, del Jiangsu Provincial Hospital, junto con los cirujanos del HCTM Dr. Adi Syazni y el Prof. Shahrun Niza, el programa de dos días combinó conferencias teóricas, discusiones de casos complejos y entrenamiento práctico con maniquíes y pacientes reales para avanzar las habilidades de MWA de los médicos y apoyar la adopción global de la terapia mínimamente invasiva.

Baird Medical (NASDAQ: BDMD)는 말레이시아 국립대학교 병원(HCTM)에서 개최된 국제 갑상선 마이크로파 절제 워크숍에 참여했습니다. 기간은 2025년 10월 1–2일입니다.

Jiangsu Provincial Hospital의 내분비학자 Xu Shuhang 박사와 HCTM의 외과의 Dr. Adi Syazni 및 Prof. Shahrun Niza가 이끄는 이틀 간의 프로그램은 이론 강의, 복잡한 사례 토의, 마네킹과 실제 환자를 활용한 현장 실습을 결합하여 의사들의 MWA 기술을 향상시키고 최소 침습 치료의 전 세계 도입을 지원했습니다.

Baird Medical (NASDAQ: BDMD) a participé à un atelier international d'ablations micro-ondes thyroïdiennes à l'Hôpital Canselor Tuanku Muhriz (HCTM), Université nationale de Malaisie, les 1er et 2 octobre 2025.

Sous la direction du Dr Shuhang Xu, endocrinologue à l'Hôpital provincial de Jiangsu, accompagné des chirurgiens de l'HCTM Dr Adi Syazni et Prof. Shahrun Niza, le programme de deux jours a combiné des conférences théoriques, des discussions de cas complexes et une formation pratique avec des mannequins et des patients vivants pour faire progresser les compétences des médecins en MWA et soutenir l'adoption mondiale d'une thérapie peu invasive.

Baird Medical (NASDAQ: BDMD) nahm an einem Internationalen Workshop zur Schilddrüsen-Mikrowellenablation im Hospital Canselor Tuanku Muhriz (HCTM), National University of Malaysia, vom 1.–2. Oktober 2025 teil.

Unter Leitung des Prof. Dr. Shuhang Xu, Endokrinologe am Jiangsu Provincial Hospital, gemeinsam mit den HCTM-Chirurgen Dr. Adi Syazni und Prof. Shahrun Niza, vereint das zweitägige Programm theoretische Vorträge, komplexe Fallbesprechungen und praktische Übungen mit Übungsphantomen und echten Patienten, um die Fähigkeiten der Ärzte in der MWA zu verbessern und die globale Einführung der minimalinvasiven Therapie zu unterstützen.

Baird Medical (NASDAQ: BDMD) شاركت في ورشة عمل دولية لاستئصال الغدة الدرقية بالموجات الدقيقة في مستشفى Canselor Tuanku Muhriz (HCTM)، الجامعة الوطنية في ماليزيا، في الفترة من 1–2 أكتوبر 2025.

بقيادة الدكتور شوهانغ شو، أخصائي الغدد الصماء في مستشفى Jiangsu Provincial، ومع جراحي HCTM الدكتور آدي سيازني والبروفسور شاهرون نيزا، جمع برنامج اليومين بين محاضرات نظرية ومناقشات حالات معقدة وتدريباً عملياً باستخدام نماذج محاكية وبشرى حية لتعزيز مهارات MWA لدى الأطباء ودعم تبني العلاج الأقل توغلاً على نطاق عالمي.

Baird Medical (NASDAQ: BDMD) 参加了在马来西亚国立大学医院 Canselor Tuanku Muhriz (HCTM) 举办的 国际甲状腺微波消融工作坊,时间为 2025年10月1-2日

由来自江苏省人民医院的内分泌科医生徐树杭博士带队,HCTM 的外科医生 Adi Syazni 博士和 Shahrun Niza 教授共同参与,为期两天的项目结合理论讲座、复杂病例讨论,以及使用人体模型和真实患者的实操培训,旨在提升医生的微波消融(MWA)技能,推动微创治疗在全球的广泛应用。

Positive
  • None.
Negative
  • None.

In the news release, Baird Medical Fosters Advanced Physician Training at International Thyroid Microwave Ablation Workshop in Malaysia, issued 21-Oct-2025 by BDMD over PR Newswire, we are advised by the company that the second paragraph, second sentence, should read "Led by a distinguished faculty, Proctor Dr. Shuhang Xu, endocrinologist at Jiangsu Provincial Hospital, alongside HCTM's B&E Surgeons Dr. Adi Syazni and Prof. Shahrun Niza, the program featured a rigorous curriculum encompassing theoretical lectures, complex case discussions, and practical training sessions using both mannequins and live patient cases." rather than "...endocrinologist at Nanjing University of Traditional Chinese Medicine..." as originally issued inadvertently. The complete, corrected release follows:

Baird Medical Fosters Advanced Physician Training at International Thyroid Microwave Ablation Workshop in Malaysia

NEW YORK, Oct. 21, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD), a global leader in minimally invasive Microwave Ablation (MWA) technology, today announced its successful participation in the Thyroid Microwave Ablation Workshop held at the Hospital Canselor Tuanku Muhriz (HCTM) of The National University of Malaysia.

The immersive two-day workshop, held from October 1–2, 2025, brought together leading surgeons and endocrinologists for intensive, hands-on training. Led by a distinguished faculty, Proctor Dr. Shuhang Xu, endocrinologist at Jiangsu Provincial Hospital, alongside HCTM's B&E Surgeons Dr. Adi Syazni and Prof. Shahrun Niza, the program featured a rigorous curriculum encompassing theoretical lectures, complex case discussions, and practical training sessions using both mannequins and live patient cases.

Baird Medical's participation reflects its commitment to advancing innovative medical technologies and ensuring their effective adoption worldwide. The workshop served as a vital platform for local physicians to refine their MWA skills under the guidance of esteemed international experts, marking a significant step in the global expansion of this minimally invasive therapy. Baird Medical continues to play an integral role in empowering physicians to deliver MWA treatments safely and effectively.

About Baird Medical

Baird Medical is a forward-thinking medical device company specializing in minimally invasive diagnostics and treatment. It is dedicated to the research and development of surgical robotic systems and innovative minimally invasive surgical instruments. Our mission is to enhance patient outcomes through precision technology and advanced diagnostic solutions. The company will foster strategic collaborations with leading academic institutions. Our vision extends beyond surgical assistance, aiming to develop intelligent systems that proactively guide diagnostic decisions and preventive healthcare strategies. As an FDA 510(k)-certified medical device company, Baird Medical's solutions have been used in over 30 prestigious hospitals and clinics across the United States, including Johns Hopkins Hospital, Tulane Medical Center, Weill Cornell Medicine, and Columbia University Medical Center. Baird Medical is also the market leader in China in thyroid microwave ablation devices and consumables. Meanwhile, the company's minimally invasive treatment products are gradually expanding their commercial presence in over 20 countries worldwide.

Forward-Looking Statements

This press release includes certain statements that are not historical facts but are forward-looking statements for purposes of the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements generally relate to future events or Baird Medical's future financial or operating performance. In some cases, you can identify forward-looking statements by terminology such as "may", "could", "should", "expect", "intend", "might", "will", "estimate", "anticipate", "believe", "budget", "forecast", "intend", "plan", "potential", "predict", "potential" or "continue", or the negatives of these terms or variations of them or similar terminology. Forward-looking statements are subject to risks, uncertainties, and other factors which could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These forward-looking statements are based upon estimates and assumptions that, while considered reasonable by Baird Medical and its management, are inherently uncertain. New risks and uncertainties may emerge from time to time, and it is not possible to predict all risks and uncertainties. You should not place undue reliance on forward-looking statements in this press release, which speak only as of the date they are made and are qualified in their entirety by reference to the cautionary statements herein. Baird Medical does not undertake any duty to update these forward-looking statements.

Actual results may vary materially from those expressed or implied by forward-looking statements based on a number of factors, including, without limitation: (1) the risk that Baird Medical may not be successful in expanding its business in China or the United States; (2) changes in general economic conditions; (3) regulatory conditions and developments; (4) changes in applicable laws or regulations; (5) the nature, cost and outcome of pending and future litigation and other legal proceedings instituted against Baird Medical or others; and (5) other risks and uncertainties from time to time described in the Registration Statement relating to the Business Combination and the transition report, including those listed under the sections titled "Risk Factors" therein, and in ExcelFin's other filings with the SEC. 

The foregoing list of factors is not exclusive. Additional information concerning certain of these and other risk factors is contained in ExcelFin's most recent filings with the SEC and in the Registration Statement described above filed by Baird Medical in connection with its business combination with ExcelFin. All subsequent written and oral forward-looking statements concerning Baird Medical, the business combination described herein or other matters attributable to Baird Medical or any person acting on its behalf are expressly qualified in their entirety by the cautionary statements above. Readers are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made. Baird Medical expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in their expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.

Contact:
Eric Huang, PR Liaison
Baird Medical Investment Holdings Ltd.
Phone: +1 (888) 508-6228
Email: ir@bairdmed.com

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/baird-medical-fosters-advanced-physician-training-at-international-thyroid-microwave-ablation-workshop-in-malaysia-302589997.html

SOURCE BDMD

FAQ

What did BDMD announce about the October 1–2, 2025 thyroid workshop in Malaysia?

BDMD said it participated in a two-day International Thyroid Microwave Ablation Workshop at HCTM to provide hands-on MWA training to local surgeons and endocrinologists.

Who led the faculty at BDMD's Malaysia workshop and what institutions are they from?

The faculty was led by Proctor Dr. Shuhang Xu from Jiangsu Provincial Hospital, together with HCTM surgeons Dr. Adi Syazni and Prof. Shahrun Niza.

What training formats were used at the BDMD Thyroid MWA Workshop on October 1–2, 2025?

The program used theoretical lectures, complex case discussions, and practical sessions with both mannequins and live patient cases.

How does BDMD describe the purpose of its participation in the Malaysia workshop?

BDMD described its participation as a commitment to advance MWA technology adoption and to help physicians refine safe, effective MWA skills.

When and where did BDMD hold the International Thyroid Microwave Ablation Workshop in 2025?

The workshop took place at Hospital Canselor Tuanku Muhriz (HCTM), National University of Malaysia, on October 1–2, 2025.
Baird Medical

NASDAQ:BDMD

BDMD Rankings

BDMD Latest News

BDMD Stock Data

52.93M
31.27M
99.92%
2.11%
0.16%
Medical Devices
Healthcare
Link
China
Guangzhou